Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Small Methods ; 6(12): e2200932, 2022 12.
Article in English | MEDLINE | ID: mdl-36300882

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies are shown to be effective therapeutics for providing coronavirus disease 2019 (COVID-19) protection. However, recurrent variants arise and facilitate significant escape from current antibody therapeutics. Bispecific antibodies (bsAbs) represent a unique platform to increase antibody breadth and to reduce neutralization escape. Herein, a novel immunoglobulin G-variable domains of heavy-chain-only antibody (IgG-VHH) format bsAb derived from a potent human antibody R15-F7 and a humanized nanobody P14-F8-35 are rationally engineered. The resulting bsAb SYZJ001 efficiently neutralizes wild-type SARS-CoV-2 as well as the alpha, beta, gamma, and delta variants, with superior efficacy to its parental antibodies. Cryo-electron microscopy structural analysis reveals that R15-F7 and P14-F8-35 bind to nonoverlapping epitopes within the RBD and sterically hindered ACE2 receptor binding. Most importantly, SYZJ001 shows potent prophylactic and therapeutic efficacy against SARS-CoV-2 in three established mouse models. Collectively, the current results demonstrate that the novel bsAb format is feasible and effective, suggesting great potential as an inspiring antiviral strategy.


Subject(s)
Antibodies, Bispecific , COVID-19 , Mice , Animals , Humans , SARS-CoV-2/genetics , Spike Glycoprotein, Coronavirus/chemistry , Immunoglobulin G/genetics , Antibodies, Bispecific/pharmacology , Cryoelectron Microscopy , Antibodies, Viral/therapeutic use
2.
Science ; 374(6566): 472-478, 2021 Oct 22.
Article in English | MEDLINE | ID: mdl-34554826

ABSTRACT

Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple mutations in SARS-CoV-2 that could impair antibody defenses propagated in human-to-human transmission and spillover or spillback events between humans and animals. To develop prevention and therapeutic strategies, we formed an international consortium to map the epitope landscape on the SARS-CoV-2 spike protein, defining and structurally illustrating seven receptor binding domain (RBD)­directed antibody communities with distinct footprints and competition profiles. Pseudovirion-based neutralization assays reveal spike mutations, individually and clustered together in variants, that affect antibody function among the communities. Key classes of RBD-targeted antibodies maintain neutralization activity against these emerging SARS-CoV-2 variants. These results provide a framework for selecting antibody treatment cocktails and understanding how viral variants might affect antibody therapeutic efficacy.


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Epitope Mapping , Immunodominant Epitopes/immunology , SARS-CoV-2/immunology , Spike Glycoprotein, Coronavirus/immunology , Antibodies, Neutralizing/therapeutic use , Antibodies, Viral/therapeutic use , Antigens, Viral/chemistry , Antigens, Viral/immunology , COVID-19/therapy , Humans , Immunodominant Epitopes/chemistry , Protein Binding , Protein Domains , Spike Glycoprotein, Coronavirus/chemistry
4.
Cell Res ; 31(1): 25-36, 2021 01.
Article in English | MEDLINE | ID: mdl-33262452

ABSTRACT

Structural principles underlying the composition and synergistic mechanisms of protective monoclonal antibody cocktails are poorly defined. Here, we exploited antibody cooperativity to develop a therapeutic antibody cocktail against SARS-CoV-2. On the basis of our previously identified humanized cross-neutralizing antibody H014, we systematically analyzed a fully human naive antibody library and rationally identified a potent neutralizing antibody partner, P17, which confers effective protection in animal model. Cryo-EM studies dissected the nature of the P17 epitope, which is SARS-CoV-2 specific and distinctly different from that of H014. High-resolution structure of the SARS-CoV-2 spike in complex with H014 and P17, together with functional investigations revealed that in a two-antibody cocktail, synergistic neutralization was achieved by S1 shielding and conformational locking, thereby blocking receptor attachment and viral membrane fusion, conferring high potency as well as robustness against viral mutation escape. Furthermore, cluster analysis identified a hypothetical 3rd antibody partner for further reinforcing the cocktail as pan-SARS-CoVs therapeutics.


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , COVID-19 , Epitopes/immunology , SARS-CoV-2/immunology , Single-Chain Antibodies/immunology , Animals , Antibodies, Neutralizing/pharmacology , Antibodies, Viral/pharmacology , COVID-19/immunology , COVID-19/prevention & control , Chlorocebus aethiops , Disease Models, Animal , Humans , Single-Chain Antibodies/pharmacology , Vero Cells
5.
Acta Virol ; 56(3): 241-6, 2012.
Article in English | MEDLINE | ID: mdl-23043604

ABSTRACT

UNLABELLED: Ophiusa disjungens is one of the main insect pests that attack Myrtaceae species. Nucleopolyhedroviruses (NPVs) of the Baculoviridae family have been used for decades as biological pesticides to control insect pests. A new NPV, named Ophiusa disjungens nucleopolyhedrovirus (OpdiNPV), was recently isolated from OpdiNPV-infected O. disjungens larvae. In this study, a PstI fragment of OpdiNPV genome containing the deoxyuridine triphosphatase (dUTPase) gene was successfully cloned, sequenced and analyzed. Upstream of a 402 bp long ORF of the dUTPase gene, encoding a 133 aa long protein, typical transcription promoter boxes CAGT and TATA were found. The dUTPase was first expressed in his-tagged form in Escherichia coli as a 35.5 kDa protein. Then it was successfully expressed in insect Trichoplusia ni (Tn) cells in the form of an EGFP-fusion protein. It first appeared (at 24 hrs post infection (p.i.)) in the cell nucleus, but later (at 72 hrs p.i.) it was excluded from the nucleus and diffusely scattered all over the cell. These findings may serve as basis for development of engineered OpdiNPVs as biopesticides to control O. disjungens and other Lepidoptera insects. KEYWORDS: Ophiusa disjungens; nucleopolyhedrovirus; dUTPase.


Subject(s)
Moths/virology , Nucleopolyhedroviruses/enzymology , Pyrophosphatases/genetics , Viral Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Molecular Sequence Data , Nucleopolyhedroviruses/classification , Nucleopolyhedroviruses/genetics , Nucleopolyhedroviruses/isolation & purification , Phylogeny , Pyrophosphatases/chemistry , Pyrophosphatases/metabolism , Sequence Alignment , Viral Proteins/chemistry , Viral Proteins/metabolism
6.
Curr Drug Targets ; 13(4): 495-501, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22280346

ABSTRACT

Acetylcholinesterase (AChE; EC 3.1.1.7) is a primary target of many insecticides including organophosphates (OP) and carbamates (CB). Because AChE is expressed in all invertebrate and vertebrate animals as a key enzyme of the cholinergic system, the toxicity of anticholinesterase insecticides to mammals and non-target species such as beneficial insects has been a great concern. In addition, the intensive use of OP and CB insecticides has resulted in the development of resistance in many insect pests, which has limited the use of anticholinesterase insecticides. Many aces encoding AChEs have been sequenced from a variety of vertebrates, insects and other invertebrates, and crystal structures of four AChEs have been determined in the past 20 years. Although the primary motifs and the three dimensional (3D) structures of different AChEs are similar, differences among AChEs are obvious. The catalytic properties and inhibition kinetics of AChEs from different groups of insects and mammals may be quite different, and two AChEs from a single insect may also show distinct differences. These differences may provide new opportunities for designing more selective insecticides for pest management.


Subject(s)
Acetylcholinesterase/drug effects , Cholinesterase Inhibitors/pharmacology , Insecticides/pharmacology , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Animals , Carbamates/pharmacology , Humans , Insecticide Resistance , Organophosphorus Compounds/pharmacology , Protein Conformation , Species Specificity
7.
Indian J Virol ; 23(3): 379-81, 2012 Dec.
Article in English | MEDLINE | ID: mdl-24293829

ABSTRACT

Ophiusa disjungens nucleopolyhedrovirus (OpdiNPV) was newly found in Guangdong Province, China. Using BamHI, EcoRI, HindIII, PstI, XhoI, XbaI digestion, the size of the OpdiNPV genome was estimated to be 92,000 base pair. The pstI-G genomic fragment of OpdiNPV was cloned and sequenced. Searches of databases identified at least four open reading frames (ORFs) within this fragment. These ORFs encode odv-e66 (EU 623602), p87/vp80 (EU 732665), odv-ec43 (EU617337) and ac108 gene (EU 732666) respectively. The phylogenetic tree of NPVs based on the combined sequences of odv-ec43 and ac108 indicated that OpdiNPV was most closely related to Mamestra configurata NPV-A and Mamestra configurata NPV-B. The characterization of OpdiNPV in this paper would provide better understanding molecular properties of this virus and be helpful in the development of the newly isolated virus as a biopesticide or an engineered pesticide to control more species of insect pests.

8.
Virus Res ; 155(1): 42-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20832435

ABSTRACT

VP37 protein of Broad bean wilt virus 2 (BBWV-2) is a multifunctional protein that binds single-strand nucleic acids, interacts with viral coat protein (CP) and potentiates the virus cell-to-cell movement in its host plant. In this study, tubule-like structures filled with virus-like particles were observed by Electron Microscopy in plasmodesmata in walls of Chenopodium quinoa leaf cells infected with BBWV-2. Immunogold labeling using VP37 protein specific antibody demonstrates that the VP37 is a component of the tubular structures. When VP37 was fused with the green fluorescent protein (VP37-GFP) and expressed in BY-2 protoplasts or in insect Tn cells, green fluorescent tubules of various lengths were produced, protruding from the surface of the expressing cells. These findings suggest that the movement of BBWV-2 between cells is mediated by the tubular structures that contain the VP37 protein, and the VP37 protein itself is capable of inducing these tubule-like structures in cells. Our results also suggest that the plant and insect cell factors involved in the tubule formation have conserved features.


Subject(s)
Chenopodium quinoa/virology , Cytoskeletal Proteins/metabolism , Fabavirus/pathogenicity , Insecta/virology , Viral Proteins/metabolism , Animals , Artificial Gene Fusion , Cell Wall/virology , Cells, Cultured , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Microscopy, Electron, Transmission , Plant Leaves/virology , Plasmodesmata/virology
9.
Genome ; 53(9): 688-97, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20924418

ABSTRACT

γ-Aminobutyric acid (GABA) is a very important inhibitory neurotransmitter in both vertebrate and invertebrate nervous systems. GABA receptors (GABARs) are known to be the molecular targets of a class of insecticides. Members of the GABAR gene family of the silkworm, Bombyx mori, a model insect of Lepidoptera, have been identified and characterized in this study. All putative silkworm GABAR cDNAs were cloned using the reverse transcriptase polymerase chain reaction (RT-PCR) and rapid amplification of cDNA ends (RACE). Bombyx mori appears to have the largest insect GABAR gene family known to date, including three RDL, one LCCH3, and one GRD subunit. The silkworm RDL1 gene has RNA-editing sites, and the RDL1 and RDL3 genes possess alternative splicing. These mRNA modifications enhance the diversity of the silkworm's GABAR gene family. In addition, truncated transcripts were found for the RDL1 and LCCH3 genes. In particular, the three RDL subunits may have arisen from two duplication events.


Subject(s)
Bombyx/genetics , Genes, Insect , Insect Proteins/genetics , Receptors, GABA/genetics , Alternative Splicing , Amino Acid Sequence , Animals , Bombyx/metabolism , Evolution, Molecular , Gene Amplification , Gene Expression Regulation , Gene Order , Genes, Duplicate , Insect Proteins/chemistry , Insect Proteins/metabolism , Molecular Sequence Data , Multigene Family , RNA Editing , Receptors, GABA/chemistry , Receptors, GABA/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , gamma-Aminobutyric Acid/metabolism
10.
BMB Rep ; 43(8): 573-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20797321

ABSTRACT

Several organophosphorus (OP) insecticides can selectively kill the silkworm maggot, Exorista sorbillans (Es) (Diptera: Tachinidae), while not obviously affecting the host (Bombyx mori) larvae, but the mechanism is not yet clear. In this study, the cDNA encoding an acetylcholinesterase (AChE) from the field Es was isolated. One point mutation (Gly353Ala) was identified. The Es-353G AChE and Es-353A AChE were expressed in baculovirus- insect cell system, respectively. The inhibition results showed that for eserine and Chlorpyrifos, Es-353A AChE was significantly less sensitive than Es-353G AChE. Meanwhile, comparison of the I(50) values of eserine, dichlorvos, Chlorpyrifos and omethoate of recombinant Es AChEs with its host (Bombyx mori) AChEs indicated that, both Es AChEs are more sensitive than B. mori AChEs. The results give an insight of the mechanism that some OP insecticides can selectively kills Es while without distinct effect on its host, B. mori.


Subject(s)
Acetylcholinesterase/genetics , Diptera/enzymology , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Amino Acid Sequence , Amino Acid Substitution , Animals , Bombyx/parasitology , Cholinesterase Inhibitors/pharmacology , Insecticides/chemistry , Molecular Sequence Data , Point Mutation , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment
11.
Virus Res ; 138(1-2): 81-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18809445

ABSTRACT

A BmNPV Bacmid with the Bmvp80 gene disrupted was constructed using the ET-recombination system in Escherichia coli to investigate the role of Bmvp80 during the baculovirus life cycle. Disruption of Bmvp80 resulted in single cell infection phenotype, whereas a rescue BmBacmid restored budded virus titers to wild type levels; however, the homologous gene Ac104 (Acvp80) from AcMNPV could not complement the BmBacmid lacking a functional Bmvp80 gene. Electron microscopy of cells transfected with BmNPV lacking functional Bmvp80 revealed that the number of nucleocapsids was markedly lower. These results suggest that Bmvp80 is essential for normal budded virus production and nucleocapsid maturation, and is functionally divergent between baculovirus species.


Subject(s)
Gene Silencing , Nucleopolyhedroviruses/genetics , Viral Proteins/genetics , Viral Proteins/metabolism , Animals , Bombyx , Cell Line , Nucleopolyhedroviruses/physiology , Species Specificity , Virus Assembly , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL